LRP6 and breast carcinoma: Two very recent reports by Bu's group showed that LRP6 was overexpressed in a subpopulation of human breast cancers [13] and, more importantly, demonstrated that activation of the Wnt signaling by overexpressing LRP6 alone was enough to induce breast cancer formation [14].